Dynavax Technologies (DVAX)

$10.14 +0.04 (0.40%)
Market Cap 1.18B
Revenue (ttm) 277.25M
Net Income (ttm) 27.31M
EPS (ttm) N/A
PE Ratio 50.50
Forward PE N/A
Profit Margin 9.85%
Debt to Equity Ratio 0.08
Volume 1,393,800
Avg Vol 1,745,288
Day's Range N/A - N/A
Shares Out 117.27M
Stochastic %K 74%
Beta 1.13
Analysts Sell
Price Target $22.67

Company Profile

Dynavax Technologies Corporation, a commercial stage biopharmaceutical company, focuses on developing and commercializing vaccines in the United States and internationally. The company offers HEPLISAV-B, a hepatitis B vaccine for prevention of infection caused by all known subtypes of hepatitis B virus in adults aged 18 years and older; and CpG 1018, the adjuvant used in HEPLISAV-B. It also develops rF1V, a plague vaccine candidate in Phase 2 clinical trial; and Z-1018, an investigational vaccin...

Industry: Drug Manufacturers - Specialty & Generic
Sector: Healthcare
Phone: 510 848 5100
Fax: 510 848 1327
Address:
2100 Powell Street, Suite 720, EmeryVille, United States
Shadow_Summit
Shadow_Summit Oct. 6 at 5:18 PM
$DVAX NXXT monthly momentum not fake July revenue 8.19M up 236 percent y y August 7.51M up 222 percent y y while burn down by about 1M per month that blend is rare for a microcap with sub 200DMA pressure
0 · Reply
Dvax2theMoon
Dvax2theMoon Oct. 6 at 3:19 PM
$DVAX another year almost over and management hasnt delivered on anything. useless . fire them all
1 · Reply
Noobnr1
Noobnr1 Oct. 6 at 6:40 AM
$NYXH Succes in Texas with thier Genio-system🥂💤🚀 $PHAR $GILD $DVAX $PFE
0 · Reply
HeliosOakCapital
HeliosOakCapital Oct. 2 at 6:39 PM
$DVAX SHOT doesn’t pop — it detonates. .30 is the launchpad. .40 is a formality. .50+ is when the doubters start lying about when they entered. 📊💥
0 · Reply
Buy_dvax100
Buy_dvax100 Oct. 2 at 1:56 PM
$DVAX 👀
0 · Reply
chrlaff01
chrlaff01 Oct. 1 at 8:03 PM
$DVAX This is how it’s supposed to work, little DVAX.
0 · Reply
KWalzz
KWalzz Oct. 1 at 5:11 PM
$DVAX good move but volume still low ...
0 · Reply
LeonT3rry
LeonT3rry Oct. 1 at 3:41 PM
$DVAX NXXT catalysts lined up with ReFuel LOI in Ontario adding cross border growth and Florida expansion targeting Gulf fleets. Monthly rev prints above 7M are the new base. I want run rate 80M plus in 2025 which supports PT 5 to 6 easy.
0 · Reply
SummitHarborEquity
SummitHarborEquity Oct. 1 at 3:19 PM
$DVAX NXXT comps the street watches are y/y rev and gallons and margin per gallon. We already saw $0.71 per gallon in 4Q and $7M plus months in 2025. Keep that cadence three to four prints and multiple expands. PT 5 to 6 not stretched
0 · Reply
Buy_dvax100
Buy_dvax100 Oct. 1 at 3:16 PM
$DVAX
0 · Reply
Latest News on DVAX
3 Of My Favorite Biotech Stocks Under $10

Sep 29, 2025, 1:15 PM EDT - 7 days ago

3 Of My Favorite Biotech Stocks Under $10

FOLD MRNA NUVB PFE

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Aug 27, 2025, 4:05 PM EDT - 5 weeks ago

Dynavax to Participate in the 2025 Wells Fargo Healthcare Conference

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

Aug 21, 2025, 8:22 AM EDT - 6 weeks ago

Dynavax's shingles vaccine shows similar immune response to GSK's shot in study

GSK

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Aug 21, 2025, 8:00 AM EDT - 6 weeks ago

Dynavax Announces Positive Topline Phase 1/2 Results Supporting Potential Best-in-Class Shingles Vaccine Profile

Dynavax Technologies: A Dip To Accumulate

Aug 11, 2025, 8:41 AM EDT - 2 months ago

Dynavax Technologies: A Dip To Accumulate

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 10:51 PM EDT - 2 months ago

Dynavax Technologies Corporation (DVAX) Q2 2025 Earnings Call Transcript

Dynavax Reports Second Quarter 2025 Financial Results

Aug 7, 2025, 4:00 PM EDT - 2 months ago

Dynavax Reports Second Quarter 2025 Financial Results

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Jul 29, 2025, 4:02 PM EDT - 2 months ago

Dynavax to Report Second Quarter 2025 Financial Results and Host Conference Call on August 7, 2025

Dynavax elects all four of its nominees after Deep Track proxy fight

Jun 11, 2025, 12:14 PM EDT - 4 months ago

Dynavax elects all four of its nominees after Deep Track proxy fight

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Jun 11, 2025, 11:01 AM EDT - 4 months ago

Dynavax Stockholders Elect All Dynavax Director Nominees at 2025 Annual Meeting

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Jun 9, 2025, 8:30 AM EDT - 4 months ago

Deep Track Capital Sends Letter to Dynavax Technologies Shareholders Offering Final Perspectives on Why Change is Needed in the Boardroom

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Jun 9, 2025, 7:30 AM EDT - 4 months ago

Dynavax Urges Stockholders to Support Its Director Nominees at June 11 Annual Meeting

Dynavax Comments on Glass Lewis Recommendation

Jun 4, 2025, 4:59 PM EDT - 4 months ago

Dynavax Comments on Glass Lewis Recommendation

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Jun 4, 2025, 9:27 AM EDT - 4 months ago

Glass Lewis Recommends Shareholders Support Deep Track's Case for Board Change at Dynavax Technologies

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

May 28, 2025, 4:10 PM EDT - 4 months ago

Dynavax to Present at William Blair's 45th Annual Growth Stock Conference

Deep Track Capital Comments on ISS Recommendation

May 23, 2025, 6:12 PM EDT - 4 months ago

Deep Track Capital Comments on ISS Recommendation

ISS backs Dynavax directors in board fight with Deep Track Capital

May 23, 2025, 1:54 PM EDT - 4 months ago

ISS backs Dynavax directors in board fight with Deep Track Capital

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

May 23, 2025, 1:44 PM EDT - 4 months ago

Leading Independent Proxy Advisory Firm ISS Recommends Stockholders Vote "FOR" All Four of Dynavax's Highly Qualified Director Nominees

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

May 21, 2025, 11:48 PM EDT - 4 months ago

Dynavax Technologies: Hepatitis-B Vaccine Specialist Looking Good

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

May 15, 2025, 4:00 PM EDT - 5 months ago

Deep Track Capital Issues Letter to Fellow Dynavax Technologies Shareholders Detailing Critical Issues in Advance of Annual Meeting

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

May 12, 2025, 7:30 AM EDT - 5 months ago

Dynavax Files Investor Presentation Highlighting Superior Strategy and Board That is Delivering Strong Financial Results and Significant Long-Term Value

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

May 7, 2025, 4:45 PM EDT - 5 months ago

Dynavax Issues Statement and Mails Letter to Stockholders Emphasizing Record Financial Results and Continued Momentum

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

May 6, 2025, 7:34 PM EDT - 5 months ago

Dynavax Technologies Corporation (DVAX) Q1 2025 Earnings Call Transcript

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

May 6, 2025, 4:01 PM EDT - 5 months ago

Dynavax Reports First Quarter 2025 Financial Results and Announces New Pipeline Programs

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

May 6, 2025, 8:00 AM EDT - 5 months ago

Deep Track Capital Releases Investor Presentation on Dynavax Technologies

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

May 1, 2025, 8:00 AM EDT - 5 months ago

Dynavax Announces Nationwide Harris Poll Survey Results Finding Americans Underestimate the Serious Consequences of Hepatitis B and Vaccine Protection Benefits

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Apr 29, 2025, 7:30 AM EDT - 5 months ago

Dynavax Highlights Superior Board Leadership Overseeing Long-Term Value Creation Strategy

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Apr 22, 2025, 4:00 PM EDT - 5 months ago

Dynavax to Report First Quarter 2025 Financial Results and Host Conference Call on May 6, 2025

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Apr 21, 2025, 4:05 PM EDT - 6 months ago

Deep Track Capital Files Definitive Proxy Statement and Sends Letter to Fellow Shareholders

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Apr 17, 2025, 7:15 AM EDT - 6 months ago

Dynavax Files Definitive Proxy Statement and Sends Letter to Stockholders

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Apr 16, 2025, 8:00 AM EDT - 6 months ago

Deep Track Capital Comments on Dynavax Technologies' Rejection of Most Recent Settlement Offer

Dynavax Files Preliminary Proxy Statement

Apr 3, 2025, 5:40 PM EDT - 6 months ago

Dynavax Files Preliminary Proxy Statement

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Mar 10, 2025, 8:00 AM EDT - 7 months ago

Deep Track Capital Sends Letter to Dynavax Technologies' Board of Directors

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Mar 6, 2025, 6:00 AM EST - 7 months ago

Dynavax Announces Convertible Debt Refinancing and Common Stock Share Repurchase

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Mar 3, 2025, 5:58 PM EST - 7 months ago

Dynavax Technologies: A Post-Earnings Assessment With Growing Market Share

Dynavax to Participate in Upcoming Investor Conferences

Feb 25, 2025, 4:10 PM EST - 7 months ago

Dynavax to Participate in Upcoming Investor Conferences

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Feb 20, 2025, 6:38 PM EST - 8 months ago

Dynavax Technologies Corporation (DVAX) Q4 2024 Earnings Call Transcript

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Feb 20, 2025, 4:01 PM EST - 8 months ago

Dynavax Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Full Year 2025 Financial Guidance

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Feb 19, 2025, 4:52 PM EST - 8 months ago

Dynavax Responds to Deep Track and Highlights Long-Term Value Creation Strategy

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Feb 19, 2025, 9:00 AM EST - 8 months ago

Deep Track Capital Nominates Four Highly Qualified Candidates for Election to Dynavax Technologies' Board of Directors at 2025 Annual Meeting

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Feb 19, 2025, 8:04 AM EST - 8 months ago

Exclusive: Investor Deep Track launches proxy fight at Dynavax, nominates 4 directors

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Feb 11, 2025, 3:11 PM EST - 8 months ago

Goldman Sachs Turns Bearish On Vaccine Maker Dynavax Amid Shingles And Hepatitis B Uncertainty

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Feb 6, 2025, 5:42 PM EST - 8 months ago

Dynavax to Report Fourth Quarter and Full Year 2024 Financial Results and Host Conference Call on February 20, 2025

Dynavax Advances Board Refreshment Program

Jan 27, 2025, 6:00 AM EST - 9 months ago

Dynavax Advances Board Refreshment Program

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Jan 13, 2025, 9:00 AM EST - 9 months ago

Dynavax Announces Preliminary Unaudited Fourth Quarter and Full Year 2024 Financial Highlights

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Nov 26, 2024, 4:05 PM EST - 11 months ago

Dynavax to Present at the 7th Annual Evercore HealthCONx Conference

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Nov 13, 2024, 6:36 PM EST - 11 months ago

Dynavax Technologies: What The Stock Buyback Means.  What It Doesn't

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Nov 11, 2024, 8:00 AM EST - 11 months ago

Dynavax Announces $100 Million Accelerated Share Repurchase Program

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Nov 7, 2024, 7:46 PM EST - 11 months ago

Dynavax Technologies Corporation (DVAX) Q3 2024 Earnings Call Transcript

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Nov 7, 2024, 4:02 PM EST - 11 months ago

Dynavax Reports Third Quarter 2024 Financial Results and Provides Business Updates

Shadow_Summit
Shadow_Summit Oct. 6 at 5:18 PM
$DVAX NXXT monthly momentum not fake July revenue 8.19M up 236 percent y y August 7.51M up 222 percent y y while burn down by about 1M per month that blend is rare for a microcap with sub 200DMA pressure
0 · Reply
Dvax2theMoon
Dvax2theMoon Oct. 6 at 3:19 PM
$DVAX another year almost over and management hasnt delivered on anything. useless . fire them all
1 · Reply
Noobnr1
Noobnr1 Oct. 6 at 6:40 AM
$NYXH Succes in Texas with thier Genio-system🥂💤🚀 $PHAR $GILD $DVAX $PFE
0 · Reply
HeliosOakCapital
HeliosOakCapital Oct. 2 at 6:39 PM
$DVAX SHOT doesn’t pop — it detonates. .30 is the launchpad. .40 is a formality. .50+ is when the doubters start lying about when they entered. 📊💥
0 · Reply
Buy_dvax100
Buy_dvax100 Oct. 2 at 1:56 PM
$DVAX 👀
0 · Reply
chrlaff01
chrlaff01 Oct. 1 at 8:03 PM
$DVAX This is how it’s supposed to work, little DVAX.
0 · Reply
KWalzz
KWalzz Oct. 1 at 5:11 PM
$DVAX good move but volume still low ...
0 · Reply
LeonT3rry
LeonT3rry Oct. 1 at 3:41 PM
$DVAX NXXT catalysts lined up with ReFuel LOI in Ontario adding cross border growth and Florida expansion targeting Gulf fleets. Monthly rev prints above 7M are the new base. I want run rate 80M plus in 2025 which supports PT 5 to 6 easy.
0 · Reply
SummitHarborEquity
SummitHarborEquity Oct. 1 at 3:19 PM
$DVAX NXXT comps the street watches are y/y rev and gallons and margin per gallon. We already saw $0.71 per gallon in 4Q and $7M plus months in 2025. Keep that cadence three to four prints and multiple expands. PT 5 to 6 not stretched
0 · Reply
Buy_dvax100
Buy_dvax100 Oct. 1 at 3:16 PM
$DVAX
0 · Reply
VectorGrid_71
VectorGrid_71 Sep. 30 at 6:03 PM
$DVAX SHOT “impossible” crowd coping again… see you at .30 😮‍💨✅
0 · Reply
Barry64
Barry64 Sep. 30 at 3:39 PM
$DVAX Just for fun, I asked Grok a.i. why the board of directors would want to keep the share price of their company suppressed. It provided me seven possible reasons. Many of the reasons didn't fit DVAX but one seem to resonate: "Discourage Hostile Takeovers: In some cases, a lower share price might be part of a broader strategy to make the company less appealing to hostile acquirers, especially if paired with defensive measures like poison pills or staggered board elections." Sound familiar?!
1 · Reply
KWalzz
KWalzz Sep. 30 at 2:38 PM
$DVAX Ryan, Scott, are you there?
0 · Reply
AccuRoger
AccuRoger Sep. 30 at 2:29 PM
$DVAX Mouse study. This Chinese Chronic HepB therapeutic use CpG 1018. It demonstrates interest in using our adjuvant. The German TherVacB therapeutic is in human trials using CpG. FYI Management has not yet acknowledged this interest in Chronic HepB. Why? Researchers see benefit. https://www.mdpi.com/2076-393X/13/10/1014
0 · Reply
Barry64
Barry64 Sep. 29 at 6:48 PM
$DVAX Mr. Myers has been a member of the Dynavax board since October 2021. He has assisted in the sale and/or acquisition of six pharma companies prior to and since joining the board including AMAG Pharmaceuticals (2020), Cascadian Therapeutics (2018), Rainier Therapeutics (2020), Aerocrine (2015), Ironshore Therapeutics (2024), Harpoon Therapeutics (2024). He has been busy as a little bee. It's time fly back home and get the DVAX hive sold! (Source: DVAX website)
1 · Reply
Estimize
Estimize Sep. 29 at 12:18 PM
Wall St is expecting 0.13 EPS for $DVAX Q3 [Reporting 10/30 AMC] http://www.estimize.com/intro/dvax?chart=historical&metric_name=eps&utm_co
0 · Reply
VictorJung
VictorJung Sep. 26 at 9:33 PM
$DVAX US manufacturing plant for sale….we give you good price!
0 · Reply
KWalzz
KWalzz Sep. 26 at 10:27 AM
$DVAX ' Heplisav antigen is manufactured in Germany, while CpG1018 is manufactured in U.S. just to note, who knows what today brings then.
0 · Reply
Buy_dvax100
Buy_dvax100 Sep. 26 at 1:12 AM
$DVAX
1 · Reply
Buy_dvax100
Buy_dvax100 Sep. 25 at 1:33 PM
$DVAX
2 · Reply
KWalzz
KWalzz Sep. 25 at 10:10 AM
$DVAX reality update on CpG1018 versus ALUM: (versus should be AND) One uneducated user here recently claimed that Alum will be announced as "the reason for Autism" (it WAS NOT it besides this being ridculous anyways) and that "CpG1018 will take off" because of Alum/Autism (again just ridculous). DVAX knows that it is often the case that CpG1018 power is improved when ALUM is ADDED - this is science reality. Based on Z1018 phase 1 results, Dynavax selected the 100 µg glycoprotein E dose adjuvanted with CpG 1018 AND ALUM and an 8-week schedule to advance into Part 2 of the trial in adults 70 and older. That is reality here, adding ALUM is important for some CpG1018 usage cases, you can't deny science. And maybe this is another reason for this stock to be weak re share price.
1 · Reply
KWalzz
KWalzz Sep. 25 at 8:02 AM
$DVAX SI update: the lowest value since 03/14/25, but still too high, but we know that DVAX is not seen as "sound" company as confirmed by low MC.
0 · Reply